Methods and compositions for the treatment of gliomas
Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
- US10568889 (Issued on February 25, 2020), licensed to Pyrefin Inc.
- US10052332 (Issued on August 21, 2018), licensed to Pyrefin Inc.
- US10040783 (Issued on August 7, 2018), licensed to Pyrefin Inc.
- US9518044 (Issued on December 13, 2016), licensed to Pyrefin Inc.
- US Patent App. 16/686,046 (Filed on November 15, 2019).